glp-1 and thyroid disease Dual Glucagon-Like Peptide-1 (GLP-1) Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Dysfunction Following Tirzepatide Use GLP-1 and Thyroid Disease: Safe

Data sources: County-level adult obesity prevalence estimates from CDC PLACES (most recent release) and Texas DSHS BRFSS

The pipeline includes investigational GLP-1 and dual agonists projected to expand these medications use to new patient populations

Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions

Daily Replenisher ingredients The powdered Replenisher targets areas where a multivitamin falls short